This inter-organelle mechanism distinguishes ATP13A2 from other PD-related genes that act primarily within the mitochondria, highlighting its dual role at the interface of lysosomal and mitochondrial quality control. This evidence concerns the gene ATP13A2 and Parkinson disease.